SANTA CLARA, Calif., Oct. 23, 2006
Agilent Technologies Inc. (NYSE: A) announced today that the National Cancer Institute (NCI) has purchased a full site license for a wide range of Agilent bioinformatics solutions.
Under the agreement, the NCI is
Read More